Skip to main content
Recall Canary
Methohexital Sodium 100 mg/10 mL
← Back to all recalls
DRUG RECALLMODERATE

Methohexital Sodium 100 mg/10 mL

QuVa Pharma is recalling Methohexital Sodium 100 mg/10 mL vials due to failed impurities and degradation specifications.

What to do

Healthcare facilities should immediately examine their inventory, quarantine the affected product, and contact the manufacturer for return instructions.

Recalled
Listed
Updated
Recall No.
D-0664-2026
Agency
FDA
Firm
QuVa Pharma, Inc.
Recall ID
99311
Status
ONGOING

Why it was recalled

QuVa Pharma is recalling Methohexital Sodium 100 mg/10 mL (10 mg/mL) compounded drug vials due to failed impurities and degradation specifications. This product is intended for professional use in clinical settings.

Is mine affected?

Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

Methohexital Sodium

Lot code
10162261, 10162262, 10162279, 10162280, 2026
Strength
100 mg
UPC
10162261, 10162262, 10162279, 10162280, 10162314, 10162315, 10162465, 10162466, 10162491, 10162492, 10162542, 10162543, 10162559, 10162560, 10162623, 10162624, 10162693, 10162694, 10162735, 10162736

Where it was sold

Distributed nationwide.

Timeline

  1. Firm initiated recall
  2. Publicly announced
  3. Listed on Recall Canary
  4. Summary updated

Official source

View on U.S. Food and Drug Administration →

Other Impurity or Degradation recalls

← Back to all recalls

Editorial summary by Recall Canary · summary updated 2026-07-08 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification